Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Briner, R M S; Fierling, Rebecca; Gerber, N U; Kamarachev, J; Arlettaz, Romaine (2018). Hashimoto-Pritzker Langerhans cell histiocytosis in a neonate. Cheseau-sur-Lausanne: Swiss Society of Neonatology.

Hoffman, Lindsey M; Veldhuijzen van Zanten, Sophie E M; Colditz, Niclas; Baugh, Joshua; Chaney, Brooklyn; Hoffmann, Marion; Lane, Adam; Fuller, Christine; Miles, Lili; Hawkins, Cynthia; Bartels, Ute; Bouffet, Eric; Goldman, Stewart; Leary, Sarah; Foreman, Nicholas K; Packer, Roger; Warren, Katherine E; Broniscer, Alberto; Kieran, Mark W; Minturn, Jane; Comito, Melanie; Broxson, Emmett; Shih, Chie-Schin; Khatua, Soumen; Chintagumpala, Murali; Carret, Anne Sophie; Escorza, Nancy Yanez; Hassall, Timothy; Ziegler, David S; Gottardo, Nicholas; et al; Grotzer, M A; Gerber, N U (2018). Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of Clinical Oncology, 36(19):1963-1972.

Boesten, T; Gerber, N U; Kandels, D; Azizi, A; Schmidt, R; Warmuth-Metz, M; Pietsch, Torsten; Kortmann, R D; Gnekow, A; Grotzer, M A (2017). Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004. Neuro-Oncology Practice, 4(1):29-39.

Gerber, N U; Mynarek, M; von Hoff, K; Friedrich, C; Resch, A; Rutkowski, S (2014). Recent developments and current concepts in medulloblastoma. Cancer Treatment Reviews, 40(3):356-365.

Warmuth-Metz, M; Bison, B; Gerber, N U; Pietsch, T; Hasselblatt, M; Frühwald, M C (2013). Bone involvement in atypical teratoid/rhabdoid tumors of the CNS. American Journal of Neuroradiology, 34(10):2039-2042.

Faoro, D; von Bueren, A O; Shalaby, T; Sciuscio, D; Hürlimann, M L; Arnold, L; Gerber, N U; Haybaeck, J; Mittelbronn, M; Rutkowski, S; Hegi, M; Grotzer, M A (2011). Expression of O(6)-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology, 103(1):59-69.

Gerber, N U; von Hoff, K; von Bueren, A O; Treulieb, W; Warmuth-Metz, M; Pietsch, T; Soerensen, N; Faldum, A; Emser, A; Schlegel, P G; Deinlein, F; Kortmann, R D; Rutkowski, S (2011). Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. Journal of Neuro-Oncology, 102(3):459-469.

von Bueren, A O; von Hoff, K; Pietsch, T; Gerber, N U; Warmuth-Metz, M; Deinlein, F; Zwiener, I; Faldum, A; Fleischhack, G; Benesch, M; Krauss, J; Kuehl, J; Kortmann, R D; Rutkowski, S (2011). Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-Oncology, 13(6):669-679.

von Bueren, A O; Oehler, C; Shalaby, T; von Hoff, K; Pruschy, M; Seifert, Burkhardt; Gerber, N U; Warmuth-Metz, M; Stearns, D; Eberhart, C G; Kortmann, R D; Rutkowski, S; Grotzer, M A (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11:74.

Benesch, M; Weber-Mzell, D; Gerber, N U; von Hoff, K; Deinlein, F; Krauss, J; Warmuth-Metz, M; Kortmann, R D; Pietsch, T; Driever, P H; Quehenberger, F; Urban, C; Rutkowski, S (2010). Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. Journal of Neurosurgery. Pediatrics, 6(2):137-144.

von Hoff, K; Hartmann, W; von Bueren, A O; Gerber, N U; Grotzer, M A; Pietsch, T; Rutkowski, S (2010). Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatric Blood & Cancer, 54(3):369-376.

von Hoff, K; Hinkes, B; Gerber, N U; Deinlein, F; Mittler, U; Urban, C; Benesch, M; Warmuth-Metz, M; Soerensen, N; Zwiener, I; Goette, H; Schlegel, P G; Pietsch, T; Kortmann, R D; Kuehl, J; Rutkowski, S (2009). Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. European Journal of Cancer, 45(7):1209-1217.

Pfister, S; Remke, M; Benner, A; Mendrzyk, F; Toedt, G; Felsberg, J; Wittmann, A; Devens, F; Gerber, N U; Joos, S; Kulozik, A; Reifenberger, G; Rutkowski, S; Wiestler, O D; Radlwimmer, B; Scheurlen, W; Lichter, P; Korshunov, A (2009). Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. Journal of Clinical Oncology, 27(10):1627-1636.

Schneider, D; Monoranu, C M; Huang, B; Rutkowski, S; Gerber, N U; Krauss, J; Puppe, B; Roggendorf, W (2009). Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis. Cancer Genetics and Cytogenetics, 191(2):90-96.

Rutkowski, S; Gerber, N U; von Hoff, K; Gnekow, A; Bode, U; Graf, N; et al (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology, 11(2):201-210.

Gerber, N U; Zehnder, D; Zuzak, T J; Poretti, A; Boltshauser, E; Grotzer, M A (2008). Outcome in children with brain tumours diagnosed in the first year of life: long-term complications and quality of life. Archives of Disease in Childhood, 93(7):582-589.

This list was generated on Tue Sep 17 06:34:06 2019 CEST.